- Malaysia
- /
- Household Products
- /
- KLSE:HEXCARE
Hextar Healthcare Berhad Second Quarter 2024 Earnings: RM0.002 loss per share (vs RM0.006 loss in 2Q 2023)
Hextar Healthcare Berhad (KLSE:HEXCARE) Second Quarter 2024 Results
Key Financial Results
- Revenue: RM34.5m (down 15% from 2Q 2023).
- Net loss: RM2.50m (loss narrowed by 58% from 2Q 2023).
- RM0.002 loss per share (improved from RM0.006 loss in 2Q 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Hextar Healthcare Berhad's share price is broadly unchanged from a week ago.
Risk Analysis
It is worth noting though that we have found 3 warning signs for Hextar Healthcare Berhad (1 can't be ignored!) that you need to take into consideration.
Valuation is complex, but we're here to simplify it.
Discover if Hextar Healthcare Berhad might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About KLSE:HEXCARE
Hextar Healthcare Berhad
An investment holding company, produces, sells, and exports household gloves, industrial gloves, and nitrile disposable gloves in Europe, Asia, North and South America, and internationally.
Adequate balance sheet low.